Drugmaker Pays $200K To End SEC Fight Over Study Leaks
A Florida pharmaceutical company will pay a $200,000 civil penalty to the U.S. Securities and Exchange Commission to end allegations it leaked medical studies that bolstered its case for approval of...To view the full article, register now.
Already a subscriber? Click here to view full article